Hong Zhong Cao
Director/Board Member at Shandong Kexing Bioproducts Co., Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yan Qing Zhao | M | 42 |
Shandong Kexing Bioproducts Co., Ltd.
 Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 8 years |
| Xue Qin Deng | M | 57 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 16 years |
| Ning Cui | F | 47 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 14 years |
| Xiao Qin Wang | F | 47 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 6 years |
| An Tang | M | 67 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 5 years |
| Hai Yan Jiang | F | 43 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 6 years |
| Jian Hong Tao | M | 66 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 5 years |
| Jiang Tao Bai | M | 47 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 8 years |
| Hong Jie Ma | F | 53 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 5 years |
| Hao Yun Liu | F | 39 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yu Mei Zhu | F | 49 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 4 years |
| Ya Xiao | F | 51 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 3 years |
| Jia Wen | F | 45 |
Shandong Kexing Bioproducts Co., Ltd.
Shandong Kexing Bioproducts Co., Ltd. Pharmaceuticals: MajorHealth Technology Shandong Kexing Bioproducts Co., Ltd. engages in the research and development, production, and sale of recombinant protein therapeutics and microbiota agents. Its products include recombinant human erythropoietin injections, recombinant human interferon a1b injections, recombinant human granulocyte stimulating factor injections, and clostridium butyricum double live bacteria powder and capsules. The company was founded on August 22, 1997 and is headquartered in Jinan, China. | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 13 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hong Zhong Cao
- Personal Network
